Upcoming Thematic Issue – Oxidative Stress in Neurodegenerative and Psychiatric Disorders – Current Psychopharmacology

CP-THEMATIC FLYER -Dr. Puneet Kumar

http://benthamscience.com/journals/current-psychopharmacology/#top

EurekAlert! – Mind and molecules — Fingerprinting psychiatric illness

Research into mood and psychotic disorders has advanced to the extent where biochemical hypotheses explaining the aetiology of a particular illness may be individualised to more accurately target one or more underlying pathology in a specific patient.

Diagnosis of mood and psychotic disorders depend solely on relatively subjective assessment of symptoms and psychometric evaluations, upon which a decision is made to prescribe one or more standardised treatment regimen. Treatment response in turn is evaluated on the same principles. All this in spite of decades’ worth of research efforts aimed at understanding the neurobiological underpinnings of these disorders.

Research into mood (depression, bipolar disorder) and psychotic disorders has advanced to the extent where biochemical hypotheses explaining the aetiology of a particular illness may be individualised to more accurately target one or more underlying pathology in a specific patient or subgroup of patients, hence achieving more effective disease modifying therapy. A “one-size fits all” paradigm is no longer a viable approach. Rather a customized regime based on individual biological abnormalities would pave the way toward more effective treatment.


Sarel J. Brand, Marisa Moller and Brian H Harvey

Division of Pharmacology and Center of Excellence for Pharmaceutical Sciences, School of Pharmacy, North-West University, Potchefstroom, South Africa.

Read more here: http://www.eurekalert.org/pub_releases/2016-02/bsp-mam021316.php